胰岛素抵抗相关高胰岛素血症的致糖尿病过程与结直肠癌相关
该研究基于GECCO和CCFR共129420名欧洲 ancestry 参与者的个体数据,采用8种分区多基因评分(PPS)代表不同致糖尿病过程,评估其与结直肠癌(CRC)风险的关联。结果显示,反映胰岛素抵抗相关高胰岛素血症的PPS(尤其是脂肪营养不良、体脂和肥胖相关)与CRC风险升高相关,而胰岛素分泌不足或无高胰岛素血症的胰岛素抵抗PPS无关。肥胖相关高胰岛素血症性胰岛素抵抗PPS还与早发性CRC风险升高相关,且在肥胖人群中关联最强。
要点
- 胰岛素抵抗相关高胰岛素血症的PPS与结直肠癌风险升高相关。
- 脂肪营养不良、体脂和肥胖相关PPS最高十分位者CRC风险增加。
- 肥胖相关高胰岛素血症PPS与早发性CRC相关,肥胖者关联最强。
核心结论
- 以胰岛素抵抗相关高胰岛素血症为特征的致糖尿病过程与结直肠癌(包括早发性)风险升高相关。
研究设计与样本
- 基于GECCO和CCFR中129420名欧洲 ancestry 参与者的个体数据,含58531例CRC患者和70889名对照,应用8种经验证的分区多基因评分(PPS)。
主要发现
- 反映胰岛素抵抗相关高胰岛素血症的PPS与CRC风险升高相关(每项p<0.001)。
- 最高十分位 vs 最低十分位:脂肪营养不良OR 1.09(95%CI 1.05,1.14),体脂OR 1.13(95%CI 1.09,1.18),肥胖OR 1.15(95%CI 1.10,1.20)。
- 胰岛素分泌不足或无高胰岛素血症的胰岛素抵抗PPS与CRC无关。
- 肥胖相关高胰岛素血症性胰岛素抵抗PPS与早发性CRC相关(最高vs最低十分位OR 1.26;95%CI 1.13,1.41),肥胖者中OR 1.75(95%CI 1.46,2.11),与BMI交互p<0.001。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 2 diabetes has been associated with increased risk of colorectal cancer (CRC), but the specific diabetogenic pathways contributing to this risk remain unclear. METHODS: We analysed individual-level data from 129,420 participants of European ancestry in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and the Colon Cancer Family Registry (CCFR), comprising 58,531 patients with CRC and 70,889 control participants. We applied eight validated partitioned polygenic scores (PPSs) representing distinct diabetogenic processes: two related to relative insulin secretion insufficiency and six to insulin resistance with varying degrees of preserved insulin secretion. Adjusted ORs and 95% CIs for CRC and early-onset CRC were estimated using conditional logistic regression. RESULTS: PPSs reflecting insulin resistance-linked hyperinsulinaemia, particularly those related to lipodystrophy, body fat and obesity, were associated with higher odds of CRC (p<0.001 for each). Compared with individuals in the lowest decile, those in the highest decile had ORs of 1.09 (95% CI 1.05, 1.14), 1.13 (1.09, 1.18) and 1.15 (1.10, 1.20) for lipodystrophy, body fat and obesity, respectively. In contrast, PPSs for insulin secretion insufficiency or insulin resistance without hyperinsulinaemia were not associated with CRC. The obesity-related hyperinsulinaemic insulin resistance PPS was also associated with higher odds of early-onset CRC (OR for top vs bottom decile=1.26; 95% CI 1.13, 1.41), with the strongest association among those with obesity (OR 1.75; 95% CI 1.46, 2.11; p value for interaction with BMI <0.001). CONCLUSIONS/INTERPRETATION: Diabetogenic processes characterised by insulin resistance-linked hyperinsulinaemia were associated with increased odds of CRC, including early-onset disease. These findings offer new insights into diabetes-CRC pathogenesis, and may inform targeted prevention strategies.
引用
- Zhou X, Sevilla-Gonzalez M, Phipps AI, et al. Diabetogenic processes for insulin resistance-linked hyperinsulinaemia are associated with colorectal cancer. Diabetologia. 2025. PMID: 41398395. doi:10.1007/s00125-025-06631-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。